|

Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation

RECRUITINGN/ASponsored by Neuromed IRCCS
Actively Recruiting
PhaseN/A
SponsorNeuromed IRCCS
Started2023-04-29
Est. completion2024-10-29
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Cortical-basal ganglia gamma oscillations are pathologically reduced in Parkinson's disease (PD) and the plasticity of the primary motor cortex (M1) is impaired. Enhancing gamma oscillations through transcranial alternating current stimulation (tACS), a non-invasive neurophysiological tool that modulates cortical rhythms, can restore this alteration. However, whether tACS-related normalization of M1 plasticity results in positive clinical effects is unknown. Motor learning is also impaired in PD and gamma oscillations play a relevant role in different forms of learning in humans. Nevertheless, whether motor learning abnormalities relate to reduced gamma oscillations in PD is another unclear issue. It can be hypothesized that gamma oscillations impairment in M1 contributes to altered motor control, plasticity and learning in PD. Accordingly, in this project, the authors intend to test whether gamma-tACS on M1 in PD patients ameliorates motor performance and learning, as objectively assessed with kinematic techniques.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* PD diagnosis

Exclusion Criteria:

* severe cognitive and psychiatric comorbidities
* H\&Y\>3
* levodopa-induced dyskinesia and tremor-dominant phenotype
* history of additional neuropsychiatric disorders
* intake of medications acting on brain excitability or plasticity
* contraindications to non-invasive brain stimulation

Conditions2

Parkinson DiseaseParkinson's Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.